Sponsor Pipeline

Yaşar Bayındır, MD Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
2
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-05 NCT07529171
HBV Reactivation in Immunocompromised Patients (REANT STUDY)
Trial sites expanded: 1 -> 16 locations
2026-08-05 NCT07529171
HBV Reactivation in Immunocompromised Patients (REANT STUDY)
date change Primary completion pushed: 2026-06-30 -> 2026-08-30
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-07-30 NCT07737340 Metabolic Liver Disease in Newly Diagnosed People Living With HIV (MASHIV-TR) Recruiting
Active Trials by Phase
Not specified
4
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT06248580 Find HDV and Determine Its Status in Turkey Chronic Hepatitis D Infection Recruiting
NCT07737340 Metabolic Liver Disease in Newly Diagnosed People Living With HIV (MASHIV-TR) HIV Infections Recruiting
NCT07529171 HBV Reactivation in Immunocompromised Patients (REANT STUDY) HBV Recruiting
NCT07459426 Entecavir Resistance-Associated Mutations in Chronic HBV Patients in Turkey (STREAM Study) Hepatitis B, Chronic Not Yet Recruiting
Disease Areas
Get alerts when Yaşar Bayındır, MD's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free